2020
DOI: 10.1007/s11547-020-01210-1
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance elastography for evaluation of renal parenchyma in chronic kidney disease: a pilot study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
19
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 30 publications
1
19
0
Order By: Relevance
“…Similar results were observed when comparing renal stiffness values obtained by MRE, which differentiated patients with CKD (5.10 kPa) from those with normally functioning kidneys (4.35 kPa). The mean stiffness in patients with CKD significantly increased from stage 1 to stage 4 148 . At stage 5 CKD (kidney failure) the renal stiffness decreased, likely due to renal hypoperfusion that can mask fibrosis 148 , 149 .…”
Section: Organ-specific Stiffnessmentioning
confidence: 97%
See 1 more Smart Citation
“…Similar results were observed when comparing renal stiffness values obtained by MRE, which differentiated patients with CKD (5.10 kPa) from those with normally functioning kidneys (4.35 kPa). The mean stiffness in patients with CKD significantly increased from stage 1 to stage 4 148 . At stage 5 CKD (kidney failure) the renal stiffness decreased, likely due to renal hypoperfusion that can mask fibrosis 148 , 149 .…”
Section: Organ-specific Stiffnessmentioning
confidence: 97%
“…The mean stiffness in patients with CKD significantly increased from stage 1 to stage 4 148 . At stage 5 CKD (kidney failure) the renal stiffness decreased, likely due to renal hypoperfusion that can mask fibrosis 148 , 149 . Furthermore, MRE was also evaluated for assessing the chronic renal allograft dysfunction.…”
Section: Organ-specific Stiffnessmentioning
confidence: 97%
“…Functional MR data provide quantifiable information about underlying tissue characteristics [ 44 , 64 ]. The combination of objective biomarkers with morphologic data makes functional MRI a powerful tool that provides comprehensive information about lesion heterogeneity and therapy-induced changes in heterogeneity [ 28 , 85 , 86 ]. Functional MRI has additional potential in the early stages of treatment efficacy evaluation and should be useful in drug development [ 86 ].…”
Section: Functional Magnetic Resonance Imagingmentioning
confidence: 99%
“…The combination of objective biomarkers with morphologic data makes functional MRI a powerful tool that provides comprehensive information about lesion heterogeneity and therapy-induced changes in heterogeneity [ 28 , 85 , 86 ]. Functional MRI has additional potential in the early stages of treatment efficacy evaluation and should be useful in drug development [ 86 ]. Some functional analyses are already part of clinical practice: diffusion-weighted MRI (DW-MRI) and perfusion imaging (DCE-MRI) [ 13 , 45 , 68 ].…”
Section: Functional Magnetic Resonance Imagingmentioning
confidence: 99%
“…The most well-established clinical application of MRE is in the detection and quantification of hepatic fibrosis (29), with accurate and reliable results, as well as high intra-and interobserver agreement (30). Recently, applications for MRE have been extended to the detection of stiffness in the brain, lung, heart, kidney, spleen, and prostate tissues (31)(32)(33)(34)(35)(36). Many studies have examined the development of the MRE technique and its clinical application.…”
Section: Introductionmentioning
confidence: 99%